Dixit Kritika, Rai Bhola, Aryal Tara Prasad, de Siqueira-Filha Noemia Teixeira, Dhital Raghu, Sah Manoj Kumar, Pandit Ram Narayan, Majhi Govinda, Paudel Puskar Raj, Levy Jens W, van Rest Job, Gurung Suman Chandra, Mishra Gokul, Lönnroth Knut, Squire Stephen Bertel, Annerstedt Kristi Sidney, Bonnett Laura, Fuady Ahmad, Caws Maxine, Wingfield Tom
Birat Nepal Medical Trust, Kathmandu, Nepal.
Department of Global Public Health, WHO Collaborating Centre On TB and Social Medicine, Karolinska Institutet, Stockholm, Sweden.
BMC Glob Public Health. 2024 Mar 24;2(1):20. doi: 10.1186/s44263-024-00049-2.
The psychosocial consequences of tuberculosis (TB) are key barriers to ending TB globally. We evaluated and compared stigma, depression, and quality of life (QoL) among people with TB diagnosed through active (ACF) and passive (PCF) case-finding in Nepal.
We prospectively recruited adults with TB diagnosed through ACF and PCF in four districts of Nepal between August 2018 and April 2019. Participants were interviewed at 8-12 weeks (baseline) and 22-26 weeks (follow-up) following treatment initiation. TB stigma was measured using an adapted Van Rie Stigma Scale (0 = no stigma to 30 = highest stigma). Depression was measured using a locally-validated Patient Health Questionnaire (PHQ-9). Mild and major depression were indicated by PHQ-9 scores 5-9 and ≥ 10, respectively. QoL was measured using the EuroQoL 5-Dimension 5-level (EQ-5D-5L) from 0 to 1 (optimal QoL); and self-rated health from 0 to 100 (optimal self-rated health).
We recruited 221 participants (111 ACF; 110 PCF) with a mean age of 48 years (standard deviation [SD] = ± 16), of whom 147/221 (67%) were men. The mean TB stigma score was 12 (SD = 7.3) at baseline and 12 (SD = 6.7) at follow-up. The most commonly perceived elements of TB stigma at baseline were that people with TB experienced guilt (110/221, 50%) and feared disclosure outside their household (114/221, 52%). Self-rated health and EQ-5D-5L scores increased from baseline to follow-up (69.3 to 80.3, p < 0.001; 0.92 to 0.9, p = 0.009). Nearly one-third of participants (68/221, 31%) had mild or major depression at baseline. The proportion of participants with major depression decreased from baseline to follow-up (11.5% vs. 5%, p = 0.012). There was a moderate, significant positive correlation between depression and stigma scores (r = 0.41, p < 0.001). There were no differences found in TB stigma, self-rated health, QoL, or prevalence of mild/major depression between ACF and PCF participants.
We found a substantial, persistent, and clustered psychosocial impact among adults with TB diagnosed through both ACF and PCF strategies in Nepal. These findings suggest an urgent need to develop effective, evidence-based psychosocial support interventions with the potential to be integrated with existing ACF strategies and routine TB service activities.
结核病(TB)的社会心理后果是全球终结结核病的关键障碍。我们评估并比较了尼泊尔通过主动病例发现(ACF)和被动病例发现(PCF)诊断出的结核病患者的耻辱感、抑郁和生活质量(QoL)。
2018年8月至2019年4月期间,我们在尼泊尔四个地区前瞻性招募了通过ACF和PCF诊断出结核病的成年人。参与者在开始治疗后的8 - 12周(基线)和22 - 26周(随访)接受访谈。使用改编后的范里耻辱感量表(0 =无耻辱感至30 =最高耻辱感)测量结核病耻辱感。使用经过本地验证的患者健康问卷(PHQ - 9)测量抑郁。PHQ - 9得分5 - 9和≥10分别表示轻度和重度抑郁。使用欧洲五维度五水平健康量表(EQ - 5D - 5L)从0到1(最佳生活质量)测量生活质量;使用0到100(最佳自我评估健康)测量自我评估健康。
我们招募了221名参与者(111名ACF;110名PCF),平均年龄48岁(标准差[SD]=±16),其中147/221(67%)为男性。基线时结核病耻辱感平均得分为12(SD = 7.3),随访时为12(SD = 6.7)。基线时最常被感知到的结核病耻辱感因素是结核病患者感到内疚(110/221,50%)以及害怕在家庭以外公开病情(114/221,52%)。自我评估健康和EQ - 5D - 5L得分从基线到随访有所增加(69.3至80.3,p < 0.001;0.92至0.9,p = 0.009)。近三分之一的参与者(68/221,31%)在基线时有轻度或重度抑郁。重度抑郁参与者的比例从基线到随访有所下降(11.5%对5%,p = 0.012)。抑郁与耻辱感得分之间存在中度、显著的正相关(r = 0.41,p < 0.001)。ACF和PCF参与者在结核病耻辱感、自我评估健康、生活质量或轻度/重度抑郁患病率方面未发现差异。
我们发现,在尼泊尔通过ACF和PCF策略诊断出结核病的成年人中,存在重大、持续且集中的社会心理影响。这些发现表明迫切需要制定有效的、基于证据的社会心理支持干预措施,有可能与现有的ACF策略和常规结核病服务活动相结合。